Endothelin isoforms and the response to myocardial stretch

Abstract

Myocardial stretch elicits a biphasic increase in developed force with a first rapid force response and a second slow force response (SFR). The rapid phase is due to an increase in myofilament Ca2+ responsiveness; the SFR, analyzed here, is ascribed to a progressive increase in Ca2+ transients. Experiments were performed in cat papillary muscles to further elucidate the signaling pathway underlying the SFR. Although the SFR was diminished by BQ-123, a similar endothelin (ET)-1-induced increase in force was not affected: 23 ± 2 vs. 23 ± 3% (not significant). Instead, BQ-123 suppressed the contractile effects of ET-2 or ET-3 (21 ± 2 and 25 ± 3% vs. −1 ± 1 and −7 ± 3% respectively, P < 0.05), suggesting that ET-2 or ET-3, but not ET-1, was involved in the SFR. Each isoform activated the Na+/H+ exchanger (NHE-1), increasing intracellular Na+ concentration by 2.0 ± 0.1, 2.3 ± 0.1, and 2.1 ± 0.4 mmol/l for ET-1, ET-2, and ET-3, respectively ( P < 0.05). The NHE-1 inhibitor HOE-642 prevented the increases in force and intracellular Na+ concentration induced by all the ET isoforms, but only ET-2 and ET-3 effects were sensitive to BQ-123. Real-time RT-PCR measurements of prepro-ET-1, -ET-2, and -ET-3 were performed before and 5, 15, and 30 min after stretch. No changes in ET-1 or ET-2, but an increase of ∼60% in ET-3, mRNA after 15 min of stretch were detected. Stretch-induced ET-3 mRNA upregulation and its mechanical counterpart were suppressed by AT1 receptor blockade with losartan. These data suggest a role for AT1-mediated ET-3 released in the early activation of NHE-1 that follows myocardial stretch.